162 related articles for article (PubMed ID: 15619670)
1. Mice lacking the integrin beta5 subunit have accelerated osteoclast maturation and increased activity in the estrogen-deficient state.
Lane NE; Yao W; Nakamura MC; Humphrey MB; Kimmel D; Huang X; Sheppard D; Ross FP; Teitelbaum SL
J Bone Miner Res; 2005 Jan; 20(1):58-66. PubMed ID: 15619670
[TBL] [Abstract][Full Text] [Related]
2. Critical role of beta3 integrin in experimental postmenopausal osteoporosis.
Zhao H; Kitaura H; Sands MS; Ross FP; Teitelbaum SL; Novack DV
J Bone Miner Res; 2005 Dec; 20(12):2116-23. PubMed ID: 16294265
[TBL] [Abstract][Full Text] [Related]
3. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts.
McHugh KP; Hodivala-Dilke K; Zheng MH; Namba N; Lam J; Novack D; Feng X; Ross FP; Hynes RO; Teitelbaum SL
J Clin Invest; 2000 Feb; 105(4):433-40. PubMed ID: 10683372
[TBL] [Abstract][Full Text] [Related]
4. The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5.
Crockett JC; Schütze N; Tosh D; Jatzke S; Duthie A; Jakob F; Rogers MJ
Endocrinology; 2007 Dec; 148(12):5761-8. PubMed ID: 17823253
[TBL] [Abstract][Full Text] [Related]
5. Generation of bone-resorbing osteoclasts from B220+ cells: its role in accelerated osteoclastogenesis due to estrogen deficiency.
Sato T; Shibata T; Ikeda K; Watanabe K
J Bone Miner Res; 2001 Dec; 16(12):2215-21. PubMed ID: 11760834
[TBL] [Abstract][Full Text] [Related]
6. Alpha9beta1: a novel osteoclast integrin that regulates osteoclast formation and function.
Rao H; Lu G; Kajiya H; Garcia-Palacios V; Kurihara N; Anderson J; Patrene K; Sheppard D; Blair HC; Windle JJ; Choi SJ; Roodman GD
J Bone Miner Res; 2006 Oct; 21(10):1657-65. PubMed ID: 16995821
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss.
Lee SK; Kalinowski JF; Jacquin C; Adams DJ; Gronowicz G; Lorenzo JA
J Bone Miner Res; 2006 May; 21(5):695-702. PubMed ID: 16734384
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte macrophage-colony stimulating factor reciprocally regulates alphav-associated integrins on murine osteoclast precursors.
Inoue M; Namba N; Chappel J; Teitelbaum SL; Ross FP
Mol Endocrinol; 1998 Dec; 12(12):1955-62. PubMed ID: 9849968
[TBL] [Abstract][Full Text] [Related]
9. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
10. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
[TBL] [Abstract][Full Text] [Related]
11. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
[TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line.
Cuetara BL; Crotti TN; O'Donoghue AJ; McHugh KP
In Vitro Cell Dev Biol Anim; 2006; 42(7):182-8. PubMed ID: 16948499
[TBL] [Abstract][Full Text] [Related]
13. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
14. Estrogen regulates the production of VEGF for osteoclast formation and activity in op/op mice.
Kodama I; Niida S; Sanada M; Yoshiko Y; Tsuda M; Maeda N; Ohama K
J Bone Miner Res; 2004 Feb; 19(2):200-6. PubMed ID: 14969389
[TBL] [Abstract][Full Text] [Related]
15. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of osteoclast activity and bone turnover in different skeletal sites.
Goldberg S; Grynpas MD; Glogauer M
Arch Oral Biol; 2016 Nov; 71():134-143. PubMed ID: 27505033
[TBL] [Abstract][Full Text] [Related]
17. Disruption of claudin-18 diminishes ovariectomy-induced bone loss in mice.
Kim HY; Alarcon C; Pourteymour S; Wergedal JE; Mohan S
Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E531-7. PubMed ID: 23299504
[TBL] [Abstract][Full Text] [Related]
18. Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis.
Wang Y; Lebowitz D; Sun C; Thang H; Grynpas MD; Glogauer M
J Bone Miner Res; 2008 Feb; 23(2):260-70. PubMed ID: 17922611
[TBL] [Abstract][Full Text] [Related]
19. A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat.
Lark MW; Stroup GB; James IE; Dodds RA; Hwang SM; Blake SM; Lechowska BA; Hoffman SJ; Smith BR; Kapadia R; Liang X; Erhard K; Ru Y; Dong X; Marquis RW; Veber D; Gowen M
Bone; 2002 May; 30(5):746-53. PubMed ID: 11996914
[TBL] [Abstract][Full Text] [Related]
20. Regulation of alphaVbeta3 and alphaVbeta5 integrins by dexamethasone in normal human osteoblastic cells.
Cheng SL; Lai CF; Fausto A; Chellaiah M; Feng X; McHugh KP; Teitelbaum SL; Civitelli R; Hruska KA; Ross FP; Avioli LV
J Cell Biochem; 2000 Mar; 77(2):265-76. PubMed ID: 10723092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]